These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31129500)

  • 41. Synthesis and antihyperglycemic activity profiles of novel thiazolidinedione derivatives.
    Bhat BA; Ponnala S; Sahu DP; Tiwari P; Tripathi BK; Srivastava AK
    Bioorg Med Chem; 2004 Nov; 12(22):5857-64. PubMed ID: 15498661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats.
    Chaudhry J; Ghosh NN; Roy K; Chandra R
    Life Sci; 2007 Feb; 80(12):1135-42. PubMed ID: 17234217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In silico designing, in vitro and in vivo evaluation of potential PPAR-γ agonists derived from aryl propionic acid scaffold.
    Kharbanda C; Alam MS; Hamid H; Ali Y; Nazreen S; Dhulap A; Alam P; Pasha MAQ
    Bioorg Chem; 2021 Jan; 106():104458. PubMed ID: 33234295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemical profiling of secondary metabolites of Eugenia uniflora and their antioxidant, anti-inflammatory, pain killing and anti-diabetic activities: A comprehensive approach.
    Sobeh M; El-Raey M; Rezq S; Abdelfattah MAO; Petruk G; Osman S; El-Shazly AM; El-Beshbishy HA; Mahmoud MF; Wink M
    J Ethnopharmacol; 2019 Aug; 240():111939. PubMed ID: 31095981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.
    Bahare RS; Ganguly S; Choowongkomon K; Seetaha S
    Daru; 2015 Jan; 23(1):6. PubMed ID: 25617150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, hypoglycaemic, hypolipidemic and PPARγ agonist activities of 5-(2-Alkyl/aryl-6-Arylimidazo[2,1-b][1,3,4]thiadiazol-5-yl)methylene-1,3-thiazolidinediones.
    Khazi MI; Belavagi NS; Kim KR; Gong YD; Khazi IA
    Chem Biol Drug Des; 2013 Aug; 82(2):147-55. PubMed ID: 23581650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3-Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7.
    Sharma H; Lather V; Grewal AS; Pandita D
    Curr Comput Aided Drug Des; 2019; 15(3):225-234. PubMed ID: 30280674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic and anticancer agents.
    Kharbanda C; Alam MS; Hamid H; Javed K; Shafi S; Ali Y; Alam P; Pasha MA; Dhulap A; Bano S; Nazreen S; Haider S
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5298-303. PubMed ID: 25442322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and
    da Silva SEB; da Silva Moura JA; Branco Júnior JF; de Moraes Gomes PAT; de Paula SKS; Viana DCF; de Freitas Ramalho EAV; de Melo Gomes JV; Pereira MC; da Rocha Pitta MG; da Rocha Pitta I; da Rocha Pitta MG
    Curr Top Med Chem; 2024; 24(14):1264-1277. PubMed ID: 38523516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents.
    Firke SD; Bari SB
    Bioorg Med Chem; 2015 Sep; 23(17):5273-81. PubMed ID: 26277757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, Docking and Anti-Inflammatory Activity of Triazole Amine Derivatives as Potential Phosphodiesterase-4 Inhibitors.
    Grewal AS; Lather V; Pandita D; Dalal R
    Antiinflamm Antiallergy Agents Med Chem; 2017; 16(1):58-67. PubMed ID: 28618988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and Evaluation of the Hypoglycemic and Hypolipidemic Activity of Sulfonamide-benzothiazole Derivatives of Benzylidene-2,4- thiazolidnedione.
    Ahmadi A; Khalili M; Sohrabi L; Delzendeh N; Nahri-Niknafs B; Ansari F
    Mini Rev Med Chem; 2017; 17(8):721-726. PubMed ID: 27903228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis and bioactivity evaluation of thiazolidinedione derivatives as partial agonists targeting PPARγ.
    Sun J; Liu HY; Zhang YH; Fang ZY; Lv PC
    Bioorg Chem; 2021 Nov; 116():105342. PubMed ID: 34536928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
    Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
    Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, structural elucidation, antioxidant, CT-DNA binding and molecular docking studies of novel chloroquinoline derivatives: Promising antioxidant and anti-diabetic agents.
    Murugavel S; Jacob Prasanna Stephen CS; Subashini R; AnanthaKrishnan D
    J Photochem Photobiol B; 2017 Aug; 173():216-230. PubMed ID: 28599239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and glucose uptake activity of some novel glitazones.
    Kar K; Krithika U; Mithuna ; Basu P; Santhosh Kumar S; Reji A; Prashantha Kumar BR
    Bioorg Chem; 2014 Oct; 56():27-33. PubMed ID: 24927033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs.
    Lee MA; Tan L; Yang H; Im YG; Im YJ
    Sci Rep; 2017 Dec; 7(1):16837. PubMed ID: 29203903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, molecular docking, and pharmacological evaluation of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Kaur A; Pathak DP; Sharma V; Wakode S
    Arch Pharm (Weinheim); 2018 Jun; 351(6):e1800008. PubMed ID: 29741797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis and in-vivo hypoglycemic evaluation of novel non - TZD'S in a type - 2 diabetic model.
    Jadhav R; Gupta-Rajoria R; Pal T; Subramanian RC
    Med Chem; 2013 Feb; 9(1):104-11. PubMed ID: 22762162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents.
    Sohda T; Mizuno K; Momose Y; Ikeda H; Fujita T; Meguro K
    J Med Chem; 1992 Jul; 35(14):2617-26. PubMed ID: 1635060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.